The AI development finance “associate”.

This paper assesses a £6.8M senior development facility (48% LTGDV, 66% LTC) for a 140-bed purpose-built student accommodation scheme at Beacon Yard, Cambridge, pre-let under a 25-year nomination agreement with a Russell Group university. GDV is £14.1M on a stabilised-income basis; profit on cost is 26.2% over a 26-month term. A forward-funding institution is in exclusivity to acquire on practical completion.

The strengths are institutional in character. The nomination agreement is executed — not in heads of terms — and fixes occupancy and rental growth for 25 years, insulating the scheme from cyclical student-demand risk. The sponsor is a specialist PBSA developer-operator with 4,000 beds delivered and under management nationally, a strong balance sheet, and existing institutional relationships. Leverage at 48% LTGDV means the facility is covered even under severe value stress.

The residual risks are delivery-side. The scheme includes a basement plant room — the single most common source of programme slippage on urban PBSA — and if the forward buyer withdrew, the fallback exit (an operational stabilised-yield sale) is to a narrower buyer pool than mainstream residential, extending the realisation timeline rather than threatening repayment.

Following rebuttals, the sponsor evidenced the forward-funder's exclusivity agreement with its long-stop date and deposit, and provided the contractor's basement methodology with a dedicated programme float. The remaining exposure is timing, not credit. We recommend proceeding to terms, with the nomination agreement and forward-funding contract assigned as security and the basement package subject to monitoring-surveyor review.

The borrower is Beacon Student Living Ltd (Co. No. 11740326), the development SPV of a specialist PBSA developer-operator with 4,000 beds delivered and under management across nine UK university cities. The group's latest consolidated accounts show turnover of £31M, EBITDA of £7.4M and net assets of £22M — a balance sheet that supports the cost-overrun guarantee without strain.

The operating track record is the differentiator: the group manages its own completed stock, so its delivery decisions are made by an owner-operator rather than a trade-and-exit developer. Its three most recent schemes (420 beds aggregate) each reached practical completion within two weeks of programme. Institutional relationships are live, evidenced by the forward-funding party already in exclusivity on this scheme.

The JV equity partner contributes £3.5M alongside the group's own capital; the JV agreement subordinates all equity returns to the senior facility. No adverse credit across the group or its directors.

A 0.5-acre brownfield site 400m from the railway station with detailed consent for 140 beds across two blocks of 5 and 6 storeys. A single pre-commencement condition remains (basement plant acoustic specification); the discharge package has been submitted and the LPA has confirmed no objection in principle.

CIL is settled at £214,000. PBSA use class carries no affordable-housing requirement in this authority. The executed nomination agreement with the university runs 25 years from practical completion with annual uplifts collared at 2% and capped at 5% — an institutionally standard structure that fixes both occupancy and income growth. The agreement is assignable to the lender as security, and assignment consent has already been obtained from the university.

Cambridge has one of the UK's most acute student-accommodation shortages: full-time student numbers have grown 14% over five years against a 4% growth in purpose-built beds, and the university's own stock waiting list exceeds 2,000. The nomination agreement makes this demand context secondary — occupancy and rent are contractual — but it underpins both the forward-funding pricing and the fallback stabilised-sale value.

Stabilised PBSA yields in Cambridge have transacted between 4.9% and 5.4% over the trailing year; the appraisal adopts 5.35%, the conservative end of the evidenced range. A 50bp outward yield shift still leaves the facility covered at 56% LTGDV.

£8.4M across 45,000 ft² (~£187/ft² for PBSA shell plus fit-out) is well benchmarked against the operator's own delivered schemes and an independent QS review. The 8% contingency is appropriate for a scheme where the standardised above-ground design is de-risked by repetition.

The basement plant room is the complexity concentrate: a fixed-price package within the main JCT contract with a national contractor, a dedicated 6-week programme float, and a contractor methodology statement reviewed at rebuttal stage. The 22-month programme is realistic; drawdowns are certified by an RICS monitoring surveyor with a specific basement milestone gate.

The primary exit is a forward-funded institutional sale on practical completion: the acquiring institution is in exclusivity with a deposit lodged and a long-stop date inside the facility term. Assignment of the forward-funding contract to the lender is a condition of the facility.

The fallback is an operational stabilised-yield sale, underwritten by the nomination agreement's contractual income. At the appraised 5.35% yield the fallback covers the facility 2.1×; even at 5.85% coverage remains 1.9×. The fallback costs time — PBSA's buyer pool is institutional and narrower than mainstream residential — but does not threaten repayment.